Sign Up to like & get
recommendations!
1
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.18888
Abstract: 1. Liu H, Wang Z, Bao F, et al; and the Dapsone Hypersensitivity Syndrome Prevention Working Group. Evaluation of prospective HLA-B*13:01 screening to prevent dapsone hypersensitivity syndrome in patients with leprosy. JAMA Dermatol. 2019;155(6):666-672. doi:10.1001/jamadermatol.2018.5360…
read more here.
Keywords:
dapsone hypersensitivity;
dapsone;
hypersensitivity syndrome;
author affiliations ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Medicine"
DOI: 10.1097/md.0000000000043073
Abstract: Rationale: Dapsone is used for treating infectious and immunological disorders, but it may cause dapsone hypersensitivity syndrome (DHS), a serious concern for medical staff. However, in non-leprotic patients, the manifestations of DHS can be atypical…
read more here.
Keywords:
report;
review;
dapsone;
dapsone hypersensitivity ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "International Journal of Dermatology"
DOI: 10.1111/ijd.17906
Abstract: The introduction of the World Health Organization's multidrug therapy (WHO‐MDT) has significantly advanced leprosy treatment. Although dapsone is a fundamental component of MDT, it presents risks of adverse drug reactions (ADR), including the potentially fatal…
read more here.
Keywords:
dapsone;
multidrug therapy;
dapsone hypersensitivity;
hypersensitivity syndrome ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2020 at "PLoS Neglected Tropical Diseases"
DOI: 10.1371/journal.pntd.0008746
Abstract: Leprosy is a stigmatizing, chronic infection which degenerates the nervous system and often leads to incapacitation. Multi-drug therapy which consists of dapsone, rifampicin and clofazimine has been effective to combat this disease. In Indonesia, especially…
read more here.
Keywords:
leprosy patients;
biomarker;
study;
hla ... See more keywords